Clinical and regulatory
News on the latest clinical and regulatory developments impacting the UK optical sector
-
Professor John Sparrow discusses how patient reported outcome measures can help practitioners manage cataracts
-
The threshold for referral has increased from 22 to 24mmHg in new NICE glaucoma guidelines
-
Ciclosporin eye drops from Santen Pharmaceuticals are now recommended for dry eye patients with severe keratitis
-
Eylea and Ozurdex receive recommendations for patients in England and Wales with sight loss due to diabetic macular oedema
-
The heads of 120 CCGs have renewed calls to remove the barriers to practitioners using the cheaper drug for patients with wet AMD